Genor Biopharma Holdings Limited (HK:6998) has released an update.
Genor Biopharma Holdings Limited has announced the resignation of Dr. Guo Feng as Chairman of the Board and Executive Director to focus on other business commitments, effective from September 12, 2024; he will continue as CEO. Concurrently, the company welcomes Mr. Weng Chengyi, previously Vice President of Finance, in his new role as Executive Director and Chief Financial Officer from the same date. The company expressed gratitude to Dr. Guo for his contributions and is looking forward to Mr. Weng’s leadership in his new position.
For further insights into HK:6998 stock, check out TipRanks’ Stock Analysis page.